概要
This workshop, through plenary and parallel sessions, will focus on current challenging topics within the global pharmaceutical/biopharmaceutical arena. Attendees from the different CMC (chemistry, manufacturing and controls) areas will be able to interact with peers from Regulatory Agencies and Industry in sessions enabling interactive cross-functional discussions.
This program was developed by the CMC Working Group of the DIA Regulatory Affairs Community.
プログラム委員会
-
Yasmin de Faria Krim, PHARMD, MSC CMC working group
Chair, CMC Working Group, DIA Regulatory Affairs Community, France -
Ursula Busse, PHD, MBA CMC Regulatory Affairs Advisor
Self employed, France -
Sabine Kopp, PHD Group Lead, Medicines Quality Assurance
World Health Organization (WHO), Switzerland -
Frank Montgomery, PHD Global Head Regulatory CMC, GRAPSQA
AstraZeneca, United Kingdom -
Elaine Morefield, PHD, RPH Vice President, Regulatory Affairs
VaxForm, LLC., United States -
Moheb M. Nasr, PHD, MS Principal
Nasr Pharma Regulatory Consulting, United States -
Dr. Peter Richardson, PHD Head of Quality, Specialised Scientific Disciplines Department
European Medicines Agency, Netherlands -
Jean-Louis Robert, PHD Former CHMP/CVMP QWP Chair
Luxembourg
